NMI Holdings, Inc. Class A Stock News

NMI Holdings, Inc. (NASDAQ:NMIH ) Q1 2025 Earnings Conference Call April 29, 2025 5:00 PM ET Company Participants John Swenson - Vice President of Investor Relations, and Treasury Brad Shuster - Executive Chairman Adam Pollitzer - President and Chief Executive Officer Aurora Swithenbank - Chief Financial Officer Conference Call Participants Mihir Bhatia - Bank of America Bose George - KBW Rick ...

EMERYVILLE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (Nasdaq: NMIH) today reported net income of $102.6 million, or $1.28 per diluted share, for the first quarter ended March 31, 2025, compared to $86.2 million, or $1.07 per diluted share, for the fourth quarter ended December 31, 2024 and $89.0 million, or $1.08 per diluted share, for the first quarter ended March 31, 2024...

EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc., (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its first quarter ended March 31, 2025 after the market close on Tuesday, April 29, 2025.

NMI Holdings, Inc. (NASDAQ:NMIH ) Q4 2024 Earnings Conference Call February 6, 2025 5:00 PM ET Company Participants John Swenson - Vice President of Investor Relations, and Treasury Brad Shuster - Executive Chairman Adam Pollitzer - President and Chief Executive Officer Aurora Swithenbank - Chief Financial Officer Conference Call Participants Doug Harter - UBS Terry Ma - Barclays Capital Bose G...

EMERYVILLE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (Nasdaq: NMIH) today reported net income of $86.2 million, or $1.07 per diluted share, for the fourth quarter ended December 31, 2024, which compares to $92.8 million, or $1.15 per diluted share, for the third quarter ended September 30, 2024 and $83.4 million, or $1.01 per diluted share, for the fourth quarter ended Decem...

EMERYVILLE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its fourth quarter and full year ended December 31, 2024 after the market close on Thursday, February 6, 2025.

The 'Undercovered' Dozen series highlights lesser-covered stocks, providing investment ideas and encouraging discussions on their potential. Arcus Biosciences is seen as a "Strong Buy" due to its promising oncology combo therapies and partnerships with Gilead and AstraZeneca. Edmund Ingham sees Sarepta Therapeutics, despite past valuation concerns, as a "Buy" with potential for >50% gain by YE2...

I recommend National Mortgage Insurance over fintech Upstart due to stark valuation disparities reminiscent of past market bubbles. National Mortgage boasts a 13% earnings yield and a P/E ratio of 7.8, significantly undervalued compared to the S&P 500 and Upstart. The company's strong credit protections and low risk of mortgage defaults make it a safer investment.